[August 15, 2008]
Dr. Gerald Soff Honored by Israel Cancer Research Fund
The Israel Cancer Research Fund (ICRF) presented Gerald A. Soff, MD, chief of the Division of Hematology and Oncology, with the organization’s Elliott Osserman Award for Distinguished Service in Support of Cancer Research.
Dr. Soff received the award in recognition of his three years of service on ICRF’s scientific review panel. ICRF’s mission is to harness Israel’s scientific talent to find a cure for cancer.
The award was named in honor of Elliott F. Osserman, MD, who was one of ICRF’s scientific founders and the first chairman of ICRF’s Scientific Advisory Board. He was internationally renowned and honored for his scientific research on the diseases multiple myeloma and amyloidosis.
“It has been a great privilege and opportunity to participate in the Israel Cancer Research Fund scientific review panel,” says Dr. Soff. “I have had the chance to work with some of the world's leading cancer scientists, to help our Israeli colleagues further their research into new understandings and treatments for cancer. Through my participation in this program, I have gained an improved appreciation for the state-of-the-art research being conducted by our Israeli colleagues, and also was able to support their work.”
SUNY Downstate Medical Center, founded in 1860, was the first medical school in the United States to bring teaching out of the lecture hall and to the patient’s bedside. A center of innovation and excellence in research and clinical service delivery, SUNY Downstate Medical Center comprises a College of Medicine, Colleges of Nursing and Health Related Professions, a School of Graduate Studies, a Graduate Public Health Program, University Hospital of Brooklyn, and an Advanced Biotechnology Park and Biotechnology Incubator.
SUNY Downstate ranks seventh nationally in the number of alumni who are on the faculty of American medical schools. More physicians practicing in New York City have graduated from SUNY Downstate than from any other medical school.